Botrytis cinerea is infected by many mycoviruses with varying phenotypical effects on the fungal host, including Botrytis virus X (BVX), a mycovirus that has been found in several B. cinerea isolates worldwide with no obvious effects on growth. Here we present results from serological and immunofluorescence microscopy (IFM) studies using antiserum raised against the coat protein of BVX expressed in Escherichia coli fused to maltose-binding protein. Due to the high yield of recombinant protein it was possible to raise antibodies that recognized BVX particles. An indirect ELISA, using BVX antibodies, detected BVX in partially purified virus preparations from fungal isolates containing BVX alone and in mixed infection with Botrytis virus F. The BVX antiserum also proved suitable for IFM studies. Intensely fluorescing spots (presumed to be virus aggregates) were found to be localized in hyphal cell compartments and spores of natural and experimentally infected B. cinerea isolates using IFM. Immunofluorescently labelled sections through fungal tissue, as well as fixed mycelia grown on glass slides, showed aggregations of virions closely associated with fungal cell membranes and walls, next to septal pores, and in hyphal tips. Also, calcofluor white staining of mature cell walls of virus-transfected Botrytis clones revealed numerous cell wall areas with increased amounts of chitin/glycoproteins. Our results indicate that some BVX aggregates are closely associated with the fungal cell wall and raise the question of whether mycoviruses may be able to move through the wall and therefore not be totally dependent on intracellular routes of transmission.
INTRODUCTION
Botrytis cinerea Pers. ex. Fries [teleomorph Botryotinia fuckeliana (de Bary) Whetzel] is a widespread phytopathogenic fungus affecting a large number of economically important vegetable and fruit crops, predominantly in temperate climates (Coley-Smith et al., 1980) . It is known to host a range of mycoviruses including dsRNA elements associated with isometric particles (Castro et al., 1999 (Castro et al., , 2003 Howitt et al., 1995; Vilches & Castillo, 1997) , bacilliform particles (Howitt et al., 1995) and also filamentous particles (Howitt et al., 2001 (Howitt et al., , 2006 . Filamentous ssRNA viruses, like Botrytis virus X (BVX) and Botrytis virus F (BVF) are unusual among mycoviruses (Pearson et al., 2009) and consequently are prime targets for studying virus-fungal interactions. Furthermore, the BVX genome has been fully sequenced (Howitt et al., 2006) , which represents an important prerequisite when developing molecular tools for monitoring, manipulation and studying the virus and its interaction with B. cinerea. BVX is a positivesense ssRNA virus with~720 nm long flexuous virus particles and has recently been designated as the type species for a newly created genus Botrexvirus (in the family Alphaflexiviridae) due to its unique genome structure. BVX does not appear to have a big impact on naturally infected B. cinerea isolates, probably due to a long relationship with this fungus, but can cause obvious phenotypical changes when transfected into BVX-free B. cinerea strains (Boine, 2012) .
Although increasing numbers of mycoviruses are being detected and sequenced, our knowledge of the interaction between most mycoviruses and their fungal hosts is still very limited (Pearson et al., 2009) . In recent years mycoviral infections have been mostly studied using PCR-based methods, often excluding immunological approaches. This is possibly due to the fact that mycoviruses often occur in very low titres and therefore the acquisition of sufficient quantities of high-quality antigens for immunological purposes is hampered (Pearson et al., 2009 ). In addition, purifying virions from fungal tissue carries a high risk of co-purifying fungal proteins resulting in cross-reactivity to the host. A possible solution to both problems is to use recombinantly expressed viral coat proteins as an antigen for antibody production. It is potentially a fast way of producing large amounts of protein and has been used by many researchers for plant viruses (Rubinson et al., 1997; Ling et al., 2000; Cerovska et al., 2003) . Where purified or recombinant viral coat proteins are available for antiserum production, antibodies have been used for serological detection of mycoviruses (Kim et al., 2008; Ro et al., 2006) . In addition, antibodies raised against dsRNA have been used to localize dsRNA in the white rot fungus Rosellinia necatrix and to monitor the spread of several dsRNA mycoviruses (Yaegashi et al., 2011) . However, we are unaware of any published studies showing the distribution of mycoviruses within intact fungal cells or mycelial networks.
Here, we describe the successful overexpression of the BVX coat protein (CP-BVX) in Escherichia coli and the production of a polyclonal antiserum. CP-BVX antibodies proved suitable for ELISA screening for BVX in partially purified fungal extracts and for immunofluorescence localization of BVX aggregates within hyphal cells of B. cinerea. Using fluorescence microscopy for localization of BVX revealed significant new aspects of the mycovirusfungus interaction.
RESULTS

Expression and purification of recombinant protein
A 570 bp PCR product encoding CP-BVX (nt 5831-6400 of the BVX genome; GenBank accession no. AY055762.1) was successfully amplified with primers containing restriction sites, cloned into pGEM-T Vector for sequencing and subcloned into the expression vectors described in Table S1 (available in JGV Online). The identity of the insert was confirmed by sequencing and an initial expression test was carried out as described in Methods. Expression of CP-BVX as a maltose-binding protein (MBP) fusion, using the pMAL-c2x-SpeI was the only system that produced soluble protein at 37 u C (Fig. 1a) . The expressed MBP-CP-BVX fusion protein was the expected size of~62 kDa, consisting of the 42 kDa MBP and 20 kDa CP-BVX. To increase the amount of soluble protein, several factors were varied, including temperature, culture time, culture medium, IPTG concentration, E. coli strain [BL21(DE3); BL21 Star BL21(DE3); Rosetta BL21(DE3)], initial cell concentration, and lysis buffer composition. The best yields were obtained when substituting Terrific broth for Luria broth and reducing the culture temperature to 18 u C. Although the cooler temperature decreased the overall protein yield, there was a greater proportion of the protein into the soluble fraction (Fig. 1b) compared with the initial experiment (Fig.  1a) . The cells were harvested by centrifugation (10 000 g) after 20 h when a density of~20 g l 21 was reached. To produce sufficient protein for immunization of rabbits, 25 g fresh weight of E. coli cells was necessary. After lysis, the cell extract was loaded onto an amylose resin column. Impurities were removed with washing buffer followed by elution of the fusion protein with elution buffer. The eluted fusion protein was digested overnight with tobacco etch virus (TEV) protease (Fig. 1b) , as off-column digestion gave better results than on-column digestion (data not shown). The identity of the liberated protein was confirmed by mass spectrometry (Agilent 7890A/5975C MSD GC-MS system).
Several attempts were made to further purify the protein by cation and anion exchange, and by size-exclusion chromatography (SEC) but CP-BVX precipitated on the ionexchange chromatography (IEC) columns or did not bind at all. During SEC the CP-BVX and MBP eluted together and could not be separated, therefore a mixture of MBP and CP-BVX was run through amylose resin to eliminate contaminating MBP before concentrating the CP-BVX for antibody production.
Evaluation of antibodies for ELISA and immunoelectron microscopy (IEM)
The antiserum was tested for its reactivity to BVX using an indirect antigen-coated plate (ACP)-ELISA and partially purified virus particles from Botrytis isolates REB655-1 (infected with BVX only) and RH106-10 (infected with BVX and BVF). The antiserum reacted strongly to partially purified BVX particles from isolate REB655-1 and RH106-10, with A 405 values of 0.441 (SD 0.010) and 0.151 (SD 0.028), respectively, compared with 20.003 (SD 0.002) and 0.013 (SD 0.005) for the two BVX-free isolates RH106-5 and REB965-1, respectively (Table S2 ). However, when crude fungal extracts in 0.2 mM phosphate buffer were used, the absorbance values for the virus positive samples were not significantly greater than those of negative controls (data not shown). This may be due to the low virus concentrations in these extracts or possibly to virus particles being aggregated and associated with cell wall and membrane fragments or other host proteins that blocked virus exposure to the antibodies.
IEM
The specificity of the CP-BVX antibodies to the BVX coat protein on intact virus particles was demonstrated using IEM (Fig. 1c) . BVX particles, possibly including linear epitopes of the coat protein, were successfully decorated with CP-BVX antibodies resulting in a strong negative staining of the virus particles (Fig. 1c) .
Epifluorescence microscopy BVX infected and non-infected Botrytis isolates were examined as mycelia grown on microscope slides (Figs 2 and 3). Intensely fluorescent 0.3-0.6 mm spots (Figs 2 and 3) were clearly distinguishable from the more diffuse autofluorescence and non-specific reactions [ Fig. 3a(i) and (iii), arrow], which was mainly found in preparations using a non-optimized staining protocol. The fluorescent spots, presumed to be BVX aggregates, were frequently found in germinating spores (Fig. 2b, c) next to the septum (Fig. 2a,  b) , and in or on the cell wall (Fig. 3f ) or in the hyphal tips ( Fig. 3c-e) . The number of virus aggregates per cell typically ranged from one to three (based on~100 observations) and were often found in clusters (Figs 2 and 3 ). Fig. 2a(iii) , #] . Fig. 3 (c-e) shows fluorescent signals in hyphal tips, the most metabolically active part of the cell. An increased number of signals could be detected during new hyphal tip growth. In Fig. 3 (c) BVX seems to be associated with the new emerging cell membrane, which could facilitate movement into the new hyphal cell. Fig.  3(d) shows a very symmetrical arrangement of three smaller (Fig. 3d, # ) virus aggregates in front of a larger aggregate (Fig. 3d, *) suggesting that the larger aggregate may have been the source of the smaller aggregates. In BVX-transfected clones [as described by Boine (2012) ] of the isolate B05-10, several BVX aggregates were observed closely associated with the membrane, similar to the findings in REB655-1 (e.g. Figs 2a and 3a) . The aggregates associated with the cell wall were much larger in the hyphal tip (Fig. 3e , *) compared with older parts of the hyphae (Fig. 3f, *) . Furthermore, BVX aggregates arrayed as clusters along the cell membrane and wall (Fig. 3f, # ) . BVX localization was also seen in ultrathin cross-sections of Botrytis hyphae originally grown on agar medium ( Fig.  4a ) with round (arrow) or irregular-shaped ( # ) virus aggregates associated with the cell membrane (Fig. 4a) , and apparently within the cell wall (Fig. 4a, * ).
Ultrathin sections of hyphae of isolate REB655-1 were also examined under the electron microscope (EM) (Fig. 4c) . Aggregations of filamentous virus-like particles with a diameter of about 400 nm, similar to earlier measurements, were found. Calcofluor white (CFW) staining of the BVX-free and BVX-infected B05-10 ( Fig. 4d) shows that the virus-infected clones have areas of extreme cell wall differentiation in mature hyphal cells in contrast to the wild type, which did not show any unusual staining.
DISCUSSION
Botrytis virus X was fully sequenced by Howitt et al. (2006) providing a molecular basis for developing tools for studying the BVX-B. cinerea interaction, including the recombinant expression of the coat protein. This allowed the production of BVX polyclonal antiserum and the development of an immunofluorescence light microscopy method to detect the virus and study its location and distribution within the mycelium and spores of B. cinerea.
The heterogeneous expression of BVX was achieved via fusion of CP-BVX to MBP. Although MBP facilitates solubility and proper folding of its fusion partner (Baneyx, 1999; Kapust & Waugh, 1999) in some cases proteins formerly bound to MBP appear to disintegrate quickly after being released from MBP. This was apparently the case for CP-BVX as we were unable to purify CP-BVX without MBP, despite various approaches including anion-and cation-exchange chromatography (IEC) and SEC. However, SEC was still a useful addition to the protocol as CP-MBP did not precipitate on the column, unlike IEC, and it revealed that free CP-BVX is stable when associated with free MBP. The free MBP may shield CP-BVX from an unfavourable environment by keeping CP-BVX in solution and natively folded. Importantly, MBP did not prevent the production of functional CP-BVX antibodies since MBP is not normally present in fungal extracts being tested for the presence of BVX.
The CP-BVX antibodies were tested for virus specificity by indirect ACP-ELISA using partially purified BVX particles. While the antiserum reacted specifically with BVX, the assay was not sufficiently sensitive to detect BVX in crude fungal extracts, presumably due to low viral titre or strong attachment of viral particles to fungal cell structures, and therefore is not a suitable replacement for PCR for routine virus detection. The antiserum was also successfully used for decoration in IEM (Fig. 1c) , demonstrating that the antibodies reacted with intact and naturally produced viral coat proteins.
Immunofluorescence microscopy (IFM) using CP-BVXspecific antibodies detected round to oval bodies (0.2-0.6 mm) in Botrytis hyphae, typically close to the cell membrane and septa, and also in conidiospores. These are presumed to be BVX aggregates and were slightly irregular (Figs 2, 3 and 4a) as would be expected for loosely bundled, non-crystalline arrangements of particles, typical of flexiviruses (Medina et al., 1998; Nolan et al., 1988; Goodman et al., 1976; Martelli et al., 2007) . This is supported by EM sections (Fig.  4c) showing aggregates similar to those formed by some flexuous plant viruses (Martelli et al., 2007) and those found in the fungus Entomophaga aulicae (Nolan et al., 1988) . Based on~100 observations, there were typically no more than three virus aggregates per hyphal cell (Fig. 2a) , possibly indicating that virus replication is regulated by the fungus, which may explain the cryptic nature of BVX infections. Segers et al. (2007) have shown that an antiviral defence mechanism exists in Cryphonectria parasitica and suggest that this might also be true for other mycovirus-fungus combinations. The low yields of BVX particles in partial purifications and the cryptic nature of natural BVX infections suggests that BVX and Botrytis have co-evolved to a balanced state where the virus titre remains low and stable.
The frequent proximity of BVX aggregates to the cell membrane supports the view that positive-strand RNA viruses of eukaryotes are, in general, closely associated with the cellular membranes of their hosts (Salonen et al., 2005) in order to acquire proteins and enzymes necessary for virus assembly. Although it is generally assumed that mycoviruses move passively through the cytoplasm by plasma streaming (Sasaki et al., 2006) , it is not known how flexuous viruses of filamentous fungi are transported from cell to cell. The occurrence of BVX aggregates next to septa may indicate that septal pores, which in B. cinerea are only about 0.2 mm wide (Gull & Trinci, 1971) , may restrict viral movement, although aggregates were observed on both sides of the septum (Fig. 2b) indicating that movement was occurring. In a hyphal tip (Fig. 3d) we observed a large aggregate and three smaller adjacent aggregates, the symmetrical arrangement of which suggests these may be derived from the larger aggregate. If this is the case, it is tempting to speculate that their movement might be facilitated by microtubules. The presence of BVX aggregates associated with the cell wall of hyphal tips points to transportation of virus particles to the apex of the cell. Newhouse et al. (1983) and Jacob-Wilk et al. (2006) suggested that membrane-bound virus-like particles could be transported by the trans-Golgi network to the hyphal tip. While BVX may also be transported by this mechanism, it does not explain the apparent localization of BVX within the cell wall. The possible secretion of mycoviruses across cell walls has previously been suggested by McCabe et al. (1999) and it is known that fungi export lipids, polysaccharides or proteins (e.g. toxins) across the cell wall in membranous vesicles (Casadevall et al., 2009) . The size of such vesicles exporting polysaccharides in the fungus Cryptococcus neoformans range from 0.06 mm to 0.3 mm (Rodrigues et al., 2008) which is similar to the size of the fluorescent spots observed in the cell wall of Botrytis isolate REB655-1. Fluorescently labelled vesicles exporting aflatoxins in Aspergillus parasiticus (Chanda et al., 2010) were also of a similar size (~0.5 mm) to the BVX aggregates found in the cell wall (Figs 2 and 3 ).
Therefore it is tempting to speculate that BVX could be secreted in membrane-bound vesicles, a means of extracellular transmission not previously recognized for mycoviruses. This might also help explain why mycoviruses are so common in some fungi (Pearson et al., 2009 ) and why BVX is present in a wide range of B. cinerea isolates (Arthur, 2007) despite the existence of many somatic incompatibility groups (Beever & Weeds, 2007) . So far the extracellular presence of mycoviruses, in the absence of cell lysis, has only been reported for Magnaporthe oryzae, where Urayama et al. (2010) were able to detect viral dsRNA in the supernatant from M. oryzae broth cultures and infect virus-free isolates by adding the dsRNA-containing supernatant. Although it is not known how the virus was released and taken up, it was the first report of a successful extracellular mycoviral uptake of a filamentous fungus. While it is possible that M. oryzae released/obtained the dsRNA through disrupted hyphae, our microscopy studies suggest that complete disruption of cell compartments may not be necessary for virus release into the surrounding environment. This idea is supported by the observation that BVX-transfected Botrytis had areas in the walls (Fig.  4d ) of mature cells, which were stained by CFW, indicating that the cell wall was undergoing differentiation. CFW specifically stains newly formed microfibrils consisting of chitin, cellulose and other b-1,4-linked carbohydrates (Hughes, 1975; Maeda & Ishida, 1967) , which are only found in actively growing hyphal tips, at newly formed branching sites and in septa. If CFW-stained areas consist of new loosely packed microfibrils, they might represent hot spots where mycoviruses could pass through the wall. If it is confirmed that virus particles can be released from fungal hyphae into the environment, the possibility of infection from the surrounding environment should be seriously considered. Changes in cell wall structure of virusinfected fungi were also observed by Buck et al. (1969) and Banks et al. (1970) , who reported that virus-containing isolates of Penicillium stoloniferum, Aspergillus foetidus and Aspergillus niger contained much greater amounts of galactosamine (which is a cell-wall component) than virusfree isolates. They concluded that the mycoviruses must have induced this alteration of the cell-wall composition.
There is a distinct absence of information on the distribution and movement of mycoviruses within their fungal hosts. Using polyclonal antibodies raised to recombinantly expressed viral coat protein, which avoids the production of antibodies to the host fungus, we were able to detect virus aggregates within hyphae and spores of B. cinerea. Data presented here demonstrate that IFM can be a very effective tool for the detection of mycoviruses in fungal hyphae and for studying the distribution and accumulation of the viruses. The significant new aspects of virus-fungal interactions revealed by our experiments may also profoundly challenge our understanding of mycoviral transmission and interaction.
METHODS
Fungal isolates. Fungal isolates used in this study were provided by Dr Ross Beever (Landcare Research, Auckland, New Zealand). REB655-1 [International Collection of Microorganisms from Plants (ICMP) # 16611] was originally isolated from strawberries grown in Auckland, New Zealand. B05-10 (ICMP # 10934) is a haploid derivative of isolate SAS56, which was isolated from grapes in Italy (Faretra et al., 1988) and has been widely used internationally as it has been completely sequenced. B05-10 was experimentally transfected with BVX and BVF as described by Boine (2012) .
Virus source and culture maintenance. Botrytis isolates RH106-10 (infected with BVX and BVF), REB655-1 (infected with BVX) and RH106-18 (infected with BVF) were provided by Dr Ross Beever. RH106-05, containing neither BVX nor BVF, was used as a negative control. Conidia for inoculation of liquid media were harvested from cultures grown on malt extract agar under a diurnal light regime. Mycelium for virus purification was grown in shake culture in Vogel's medium N (Vogel, 1956) , supplemented with 0.5 % sucrose and 0.5 % yeast extract. Flasks containing 150 ml medium were inoculated with conidia to 10 6 ml 21 and incubated for 2 days on an orbital shaker (200 r.p.m.) at 20 uC.
RNA isolation. Total RNA was extracted from either spores or mycelium using a TRIzol-based method as recommended by the manufacturer (Invitrogen). Each reaction contained either 10 7 spores or 20-50 mg tissue. For cell disruption, samples were placed in a 2.0 ml polypropylene tube and frozen at 280 uC for at least 2 h. A 5 mm stainless steel ball was added and the sample tubes placed in a pre-cooled tube holder of a Qiagen TissueLyser II (Retsch) and shaken for 1 min at maximum power. Following disruption, 500 ml of TRIzol (Invitrogen) was added, the samples incubated at room temperature for 5 min and then centrifuged for 5 min at 16 000 g in a bench-top microcentrifuge (Eppendorf). From here onwards, the manufacturer's protocol was followed. The extracted RNA was stored at 280 uC.
Virus partial purification. The fungal mycelium and spores from a 2 day liquid culture were harvested by centrifugation (10 000 g for 20 min). The pellet was washed once in distilled water and vacuum filtered through a Whatman filter paper (grade #1, 9.0 cm). The filter IP: 54.70.40.11
On: Sun, 04 Aug 2019 01:55:46 cake was either used immediately or stored at 220 uC until required. Virus particles were partially purified as described by Howitt et al. (1995) with the following changes. After chloroform extraction the homogenized mycelium was centrifuged at 10 000 g for 30 min at 4 uC. The upper aqueous phase was transferred to a 15 ml centrifuge tube, mixed with 0.02 g NaCl ml 21 and 0.12 g PEG6000 ml 21 and shaken in an ice bath at 130 r.p.m. for 1 h. The mixture was then centrifuged at 16 000 g for 20 min at 4 uC and the supernatant discarded. The pellet was resuspended in 500 ml ice-cold 20 mM phosphate buffer pH 7.0 (Invitrogen) before adding another 15 ml 20 mM phosphate buffer (pH 7.0), and storing at 4 uC overnight. After centrifugation at 6000 g for 10 min, the supernatant was made up to 10 ml with 20 mM phosphate buffer and ultracentrifuged at 120 000 g for 2 h at 4 uC. The pellet was resuspended in 500 ml 20 mM phosphate buffer and centrifuged at 10 000 g for 5 min. The supernatant was examined immediately or stored at 4 uC for up to 48 h.
Electron microscopy. Five millimetre mycelia/agar plugs were cut from 2 weeks old Botrytis cultures and fixed in 2.5 % glutaraldehyde in 0.1 M Sörensen's phosphate buffer (72 % 0.2 M Na 2 HPO 4 ?2H 2 O and 28 % NaH 2 PO 4 ?H2O, pH 7.2) for 3 h or overnight at 4 uC.
Afterwards the agar cubes (565 mm) were washed in Sörensen's phosphate buffer three times for 10 min each. The samples were then put through a dehydration series of 30 %, 50 %, 70 %, 90 %, 100 % ethanol twice, followed by 100 % acetone twice, with 10 min in each solution. After dehydration, samples were infiltrated with an epoxy resin EPON 812 (SPI-CHEM)-acetone mixture (1 : 1) for 1 h, followed by another infiltration step using 100 % epoxy resin (812). The agar/resin pieces were then transferred to 8 mm embedding capsules (Electron Microscopy Sciences), filled up with fresh resin and cured at 60 uC for 48 h. The cured samples were cut into semi-thin sections (1-5 mm) with a glass knife and stained in 0.5 % aqueous methylene blue (Sigma-Aldrich). Ultrathin sections (~70 nm) were cut with a microtome (Leica CM1850) and placed on copper grids (200 mm mesh) and stained with 2 % aqueous uranyl acetate (UA; Sigma-Aldrich) for 20 min and then with Reynolds' lead citrate [80 mM Pb(NO 3 ) 2 , 0.1 M Na 3 C 6 H 5 O 7 . 2H 2 O (sodium citrate), and 16 % 1 M NaOH] for 10 min. The stained grids were examined immediately with a Phillips CM12 electron microscope(EM).
For immuno-decoration of virus particles, Formvar-coated, carbonstabilized 200 mesh grids ( # GSCu400F-50, ProSciTech) were floated on a virus solution, diluted 1 : 50 in 0.02 M phosphate buffer, for 20 min at room temperature. The virus-coated grids were then decorated with BVX antiserum diluted 1 : 50 in 0.02 M phosphate buffer, and incubated for 15 min at room temperature. After incubation with the antibody solution the grids were washed in phosphate buffer (0.02 mM, pH 7.0) and stained with 2 % UA for 30 s before transmission EM observation.
Construction of vectors expressing CP-BVX. A clone containing the complete coat protein sequence of BVX (GenBank accession no. AY055762.1; Howitt et al., 2006) was used for PCR amplification of the coat protein gene with primers containing appropriate restriction sites (Table S1 ). Three different expression vectors were used: (i) pET22b(+) (Novagen) for production of N-and C-terminally hexahistidine-tagged proteins; (ii) pET-41a(+) (Novagen) for the production of a glutathione S-transferase (GST) fusion protein; (iii) and pMAL-c2x (New England Biolabs) for production of an MBP fusion protein. Both pET-41a(+) and pMAL-c2x had been previously modified to insert a SpeI restriction site using QuikChange Site-Directed Mutagenesis (Stratagene) as described by Kingston et al. (2004) . For the GST and MBP fusion proteins, the forward primers (Table S3 ) encoded a cleavage site for the tobacco etch virus (TEV) protease in order to allow release of CP-BVX, without non-native residues at the N terminus, following purification.
The success of CP-BVX amplification was evaluated by agarose gel electrophoresis and visualized with crystal violet without exposure to UV light. Bands of the expected size were excised and purified with a QIAquick Gel Extraction kit (Qiagen). Purified DNA was cloned into pGEM-T vector (Promega) and then transformed into DHa-5 competent cells (Invitrogen) for sequencing. pGEM-T vectors with correct inserts and their respective expression vectors were digested using appropriate restriction enzymes (Table S3 ) at 37 uC for 1 h. Vector and insert were ligated using 3 Weiss units T4 ligase (Invitrogen) and incubated overnight at 4 uC. All restriction enzymes were sourced from New England Biolabs.
Expression and purification of MBP-CP-BVX fusion protein and antibody production. Of the four vectors evaluated for expression of soluble protein under standard conditions (Riggs, 2000) only pMAL-c2x produced soluble protein. Expression was performed in Terrific broth medium (Invitrogen), instead of the more commonly used LB medium, with 0.5 % glycerol and 100 mg ampicillin ml 21 (both from Invitrogen). Induction of the recombinant protein expression was achieved by the addition of 0.3 mM IPTG (Invitrogen) to an actively growing cell culture (OD 600 : 0.8) followed by incubation in baffled flasks shaken at 190 r.p.m. for 20 h at 18 uC on an orbital shaker. Bacterial cells were harvested by centrifugation, resuspended in lysis buffer [25 mM MOPS-KOH, pH 7.0, 150 mM NaCl, 2 mM EDTA, 'Complete Protease Inhibitor Cocktail Tablets' (Roche Diagnostics) and 5 % glycerol] at a ratio of 1 : 10 (w/v) and stored at 280 uC until required. The chilled suspension was sonicated and the supernatant passed through an amylose column (New England Biolabs) according to the manufacturer's instructions. After thorough washing with three column volumes of washing buffer (25 mM MOPS-KOH, pH 7.0, 150 mM NaCl), the MBP-CP-BVX was eluted in 5 ml fractions with lysis buffer containing 20 mM maltose. Each fraction was analysed for the presence of recombinant protein by SDS-PAGE. Fractions containing most MBP-CP-BVX were pooled and incubated with TEV protease (Invitrogen) overnight, according to the manufacturer's recommendations. CP-BVX was then separated from MBP by running the protein mixture through the amylose resin column again. The CP-BVX was concentrated using a Vivaspin 2 concentrator (10 000 MWCO Hydrosart, Sartorius Stedim Biotech) to about 200 mg ml 21 and sent to AgResearch (Hamilton, New Zealand) for antibody production. The concentration of the purified CP-BVX was measured using a NanoDrop spectrophotometer (Wilmington) and purity was evaluated by SDS-PAGE. The concentrated CP-BVX was resuspended in lysis buffer plus Freund's complete adjuvant (1 : 1.5; Sigma-Aldrich) at 200 mg protein ml 21 and used to immunize two New Zealand White rabbits followed by three subsequent immunizations of 100 mg protein in Freund's incomplete adjuvant at 2 week intervals. A terminal bleed was done 7 days after the final immunization and IgG fractions were purified from crude antisera by ammonium sulphate precipitation followed by dialysis. Antibody concentration was estimated based on the specific extinction coefficient A 280 51.4 (1.0 mg ml 21 ).
ELISA. The antiserum raised to CP-BVX was tested for its reactivity to BVX using indirect antigen-coated plate (ACP)-ELISA. Rabbit IgG (non-reactive with BVX) was used as a negative antibody control. Partially purified BVX, as described above, was resuspended in coating buffer [15 mM Na 2 CO 3 , 35 mM NaHCO 3 , 2 % polyvinylpyrrolidone (PVP, M r 36 000; Sigma-Aldrich), 0.02 % NaN 3 , pH 9.6] for at least 15 min and 100 ml aliquots of virus dilutions (in coating buffer) were placed in a 96-well MICROLON 600-Microplate (Greiner Bio-One North America) and incubated for 1 h at 37 uC in a humid box. The plates were washed five times with PBS and Tween 20 (PBST) and blocked with PBST containing 5 % non-fat dried milk powder (Anchor) at 37 uC for 1 h. After another wash step, 100 ml of a 1 : 1000 dilution of BVX-antiserum in ECI buffer [PBST with 2 % PVP (Mr 36 000), 0.2 % BSA, 0.02 % NaN 3 , pH 7.4]
On: Sun, 04 Aug 2019 01:55:46 was placed in each well and the plate incubated in a humid box overnight at 4 uC. After washing, the plate was blocked, as described above, and washed again. A 1 : 500 dilution of goat-anti rabbit IgG conjugated with alkaline phosphatase (ImmunoPure) in ECI buffer was added to each well and incubated for 2 h in a humid box at 37 uC. After washing, 100 ml of PNP solution (0.5 mM MgCl 2 ?6H 2 O, 0.02 % NaN 3 , 0.92 M diethanolamine, 2.7 mM p-nitrophenyl phosphate, pH 9.8) was added to each well and the plate incubated at room temperature in the dark for at least 60 min. A 405 was measured at regular intervals with Spectra MAX 340 PC plate reader (Molecular Devices). The mean signal to noise ratio for each sample was determined by dividing the mean absorbance of each sample by the mean absorbance of the negative control. The positive/negative threshold of the assay was set at three times the negative control.
Epifluorescence microscopy and calcofluor-white (CFW) staining. A 100 ml aliquot of Botrytis spores (10 5 spores ml 21 in Vogel's medium) was applied to the surface of a sterilized glass microscope slide and incubated for periods ranging from 1.5 to 24 h at 20 uC. Prior to fixation the germinated spores were washed with 16 PBS. The specimens were fixed with 4 % paraformaldehyde (Sigma-Aldrich) for 10 min at room temperature and stopped by washing the specimen in cold 16 PBS. The fixed specimen was then permeabilized with 0.1 % Triton-X in PBS for 5 min at room temperature, washed with 16 PBS and blocked with 10 % BSA in PBS for 1 h at room temperature. The blocking buffer was removed and the primary antibody solution (BVX-antiserum diluted 1 : 1000 in blocking buffer) was added and incubated for 1 h at room temperature. Non-BVX-reactive rabbit IgG was used as a negative control to identify any non-specific fluorescence due to insufficient removal of rabbit antibodies. The primary antibody was removed by washing with PBS and the secondary antibody [anti-rabbit IgG conjugated with FITC (ImmunoPure) diluted 1 : 500 in blocking buffer] was applied and incubated for 1 h at room temperature before washing with PBS. The sample was mounted in ProLong Gold (Invitrogen), sealed and cured overnight. The following day slides were examined and photographed using an Axioplan2-Axiocam HRC microscope (Zeiss) under bright field and blue light (~470 nm) conditions. Bright field and FITC images were overlaid using Adobe Photoshop 5.0 (Adobe). The intense fluorescent spots were not seen in the healthy control (Fig. 4b) .
Ultrathin cross-sections of hyphal tubes were also examined. The preparation and fixation of specimens prior to labelling were carried out by P. W. Southerland (Plant & Food, Auckland, New Zealand) and followed the protocol described by Johnston et al. (2006) . CFW staining was performed as described by Gull & Trinci (1974) .
